Aytu BioScience, Inc. (NASDAQ:AYTU) Investor Alert: Investigation Over Possible Violations of Securities Laws

An investigation for investors in Aytu BioScience, Inc. (NASDAQ:AYTU) shares over potential securities laws violations by Aytu BioScience, Inc. was announced.

San Diego, CA — (SBWIRE) — 01/31/2022 — An investigation was announced on behalf of investors of Aytu BioScience, Inc. (NASDAQ: AYTU) shares over potential securities laws violations by Aytu BioScience, Inc. and certain of its directors and officers in connection with certain financial statements.

Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm focuses on whether a series of statements by Aytu BioScience, Inc. (NASDAQ: AYTU regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Englewood, CO based Aytu BioPharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. Aytu BioScience, Inc. reported that its Total Revenue rose from $27.63 million for the 12 months period that ended on June 30, 2020 to $65.63 million for the 12 months period that ended on June 30, 2021, and that its Net Loss over those respective time periods increased from $13.62 million to $58.28 million..

Shares of Aytu BioScience, Inc. (NASDAQ: AYTU) declined from $29.90 per share in March 2020 to as low as $1.06 per share on January 24, 2022.

Those who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/aytu-bioscience-inc-nasdaqaytu-investor-alert-investigation-over-possible-violations-of-securities-laws-1352573.htm

Media Relations Contact

Michael Daniels
Shareholders Foundation
Telephone: 1-858-779-1554
Email: Click to Email Michael Daniels
Web: https://www.shareholdersfoundation.com/